0,845  0,005  Caspase 9 stimulant
0,800  0,009  Antineoplastic (breast cancer)
0,798  0,008  Antineoplastic (lung cancer)
0,786  0,007  Antihypercholesterolemic
0,748  0,010  Antineoplastic (colorectal cancer)
0,737  0,011  Antineoplastic (colon cancer)
0,742  0,024  Apoptosis agonist
0,717  0,005  Cardiovascular analeptic
0,708  0,019  Transcription factor NF kappa B inhibitor
0,684  0,007  NOS2 expression inhibitor
0,687  0,015  TNF expression inhibitor
0,691  0,032  Antiinflammatory
0,653  0,006  Antipyretic
0,654  0,009  Antineoplastic (cervical cancer)
0,652  0,023  CYP3A4 substrate
0,616  0,005  Tubulin antagonist
0,603  0,012  Proliferative diseases treatment
0,607  0,017  Prostate cancer treatment
0,598  0,024  Teratogen
0,558  0,005  Antineoplastic (squamous cell carcinoma)
0,561  0,015  UGT1A9 substrate
0,560  0,014  AR expression inhibitor
0,549  0,005  Hepatoprotectant
0,564  0,024  Aldehyde oxidase inhibitor
0,549  0,010  Hypoxia-inducible factor 1 alpha inhibitor
0,561  0,026  CYP2C9 substrate
0,532  0,007  P-glycoprotein inhibitor
0,531  0,009  Antidiabetic symptomatic
0,525  0,004  Pneumotoxic
0,541  0,022  Antineoplastic (ovarian cancer)
0,535  0,017  Cytostatic
0,553  0,035  Antineoplastic (solid tumors)
0,526  0,018  Hepatic disorders treatment
0,527  0,021  Antineoplastic (melanoma)
0,532  0,028  Embryotoxic
0,514  0,011  Antimitotic
0,533  0,034  Antileukemic
0,498  0,009  Antineoplastic (carcinoma)
0,507  0,019  Caspase 3 stimulant
0,502  0,022  Sensitization
0,504  0,024  Cytotoxic
0,500  0,022  CTGF expression inhibitor
0,490  0,012  UGT2B4 substrate
0,472  0,004  Alpha tubulin antagonist
0,506  0,039  Antibacterial
0,483  0,019  Antineoplastic (non-small cell lung cancer)
0,497  0,034  Immunosuppressant
0,479  0,030  CYP2C19 substrate
0,471  0,024  NOS3 expression inhibitor
0,454  0,010  Calcium channel activator
0,447  0,012  Antineoplastic (sarcoma)
0,459  0,025  Antioxidant
0,437  0,007  VCAM1 expression inhibitor
0,453  0,027  Antineoplastic (glioma)
0,469  0,043  Antipruritic, allergic
0,448  0,024  Antineoplastic (multiple myeloma)
0,447  0,028  Antineoplastic (brain cancer)
0,438  0,021  Nitric oxide antagonist
0,426  0,015  RNA-directed DNA polymerase inhibitor
0,418  0,009  Topoisomerase II inhibitor
0,409  0,004  Beta tubulin antagonist
0,433  0,029  Carcinogenic
0,419  0,022  UGT1A6 substrate
0,429  0,032  Antineoplastic (pancreatic cancer)
0,415  0,019  UDP-glucuronosyltransferase substrate
0,419  0,025  Antineoplastic (glioblastoma multiforme)
0,389  0,005  Antineoplastic antibiotic
0,394  0,012  UGT2B7 substrate
0,428  0,046  Ulceration
0,399  0,021  Antineoplastic (endocrine cancer)
0,404  0,026  Antineoplastic (lymphoma)
0,405  0,029  Mutagenic
0,396  0,020  Antiulcerative
0,407  0,037  ICAM1 expression inhibitor
0,388  0,018  Abortion inducer
0,398  0,029  Free radical scavenger
0,400  0,038  Cardioprotectant
0,369  0,011  Lipid peroxidase inhibitor
0,377  0,025  Sodium/bile acid cotransporter inhibitor
0,367  0,017  Contraceptive
0,394  0,045  Respiratory analeptic
0,357  0,013  Genotoxic
0,374  0,031  Chemopreventive
0,361  0,019  Antimutagenic
0,381  0,042  Lipoxygenase inhibitor
0,349  0,016  Melanin inhibitor
0,345  0,012  UGT2B15 substrate
0,353  0,036  Antineoplastic (osteosarcoma)
0,378  0,063  Vasodilator, peripheral
0,372  0,059  Antiallergic
0,319  0,007  Expectorant
0,325  0,017  Lipocortins synthesis antagonist
0,333  0,025  UGT1A1 substrate
0,332  0,025  UGT1A4 substrate
0,320  0,013  Neurotrophic factor enhancer
0,380  0,073  CYP2C19 inhibitor
0,354  0,048  Antiosteoporotic
0,347  0,042  Antiprotozoal (Leishmania)
0,311  0,007  Topoisomerase II alpha inhibitor
0,342  0,038  Antineoplastic (small cell lung cancer)
0,315  0,015  Protein kinase stimulant
0,316  0,019  Antipruritic, non-allergic
0,307  0,011  DNA intercalator
0,352  0,065  Bone diseases treatment
0,313  0,027  Tyrosine 3 hydroxylase inhibitor
0,347  0,061  Antifungal
0,317  0,033  Antineoplastic enhancer
0,338  0,055  Analeptic
0,325  0,048  DNA damaging
0,283  0,007  UGT2B10 substrate
0,333  0,058  Spasmolytic
0,312  0,038  Antineoplastic (bladder cancer)
0,296  0,022  UGT1A3 substrate
0,281  0,013  UGT2B9 substrate
0,329  0,072  Antithrombotic
0,266  0,017  Antineoplastic (bone cancer)
0,271  0,024  Interferon gamma antagonist
0,318  0,074  Apoptosis antagonist
0,297  0,053  Antineoplastic (renal cancer)
0,291  0,050  5 Hydroxytryptamine uptake stimulant
0,246  0,006  Arachidonic acid antagonist
0,246  0,010  Microtubule formation inhibitor
0,252  0,017  Antifungal enhancer
0,269  0,043  Antihypotensive
0,243  0,018  Topoisomerase I inhibitor
0,284  0,060  GST M1-1 substrate
0,295  0,070  CYP1A2 substrate
0,286  0,063  Chemoprotective
0,231  0,010  Androgen antagonist
0,234  0,013  Antieczematic
0,271  0,052  Antiparasitic
0,273  0,054  DNA synthesis inhibitor
0,216  0,004  Acetylcholine release stimulant
0,239  0,029  NOS3 expression enhancer
0,270  0,063  Antineoplastic (liver cancer)
0,216  0,010  Antineoplastic alkaloid
0,298  0,093  Cholesterol antagonist
0,290  0,087  CYP2D6 substrate
0,207  0,009  Antineoplastic (uterine cancer)
0,229  0,034  Amylase inhibitor
0,195  0,005  UGT2B11 substrate
0,225  0,034  Liver fibrosis treatment
0,212  0,023  Alkylator
0,306  0,120  Antiprotozoal
0,212  0,027  Aldose reductase substrate
0,242  0,060  Antihypertriglyceridemic
0,220  0,038  LDLR expression enhancer
0,250  0,071  Antiamyloidogenic
0,231  0,053  Antihelmintic
0,208  0,030  Antirickettsial
0,227  0,052  Nitric-oxide synthase stimulant
0,191  0,016  Mucolytic
0,214  0,043  Antineoplastic (gastric cancer)
0,234  0,063  Peptidyltransferase inhibitor
0,180  0,011  Antiviral (Trachoma)
0,185  0,017  Contraceptive female
0,176  0,009  Ca2+-transporting ATPase inhibitor
0,237  0,075  Antineoplastic (lymphocytic leukemia)
0,258  0,098  CYP2D6 inhibitor
0,168  0,010  Postmenopausal disorders treatment
0,238  0,080  Tumour necrosis factor alpha release inhibitor
0,248  0,094  Radioprotector
0,160  0,007  Androgen agonist
0,193  0,043  ATPase inhibitor
0,162  0,012  Anabolic
0,157  0,010  Aldose reductase inhibitor
0,266  0,119  Vasodilator, coronary
0,158  0,013  SULT1E1 substrate
0,192  0,049  Toxic, respiratory center
0,162  0,022  Antiviral (Influenza B)
0,173  0,033  Interleukin 4 antagonist
0,185  0,045  Anesthetic
0,171  0,032  Autism spectrum disorders treatment
0,163  0,024  Photosensitizer
0,171  0,033  Cystathionine beta-synthase inhibitor
0,168  0,030  Growth stimulant
0,150  0,013  Aromatase inhibitor
0,222  0,088  Vasodilator
0,148  0,016  Contraceptive male
0,158  0,029  Choleretic
0,200  0,074  Antiviral (Influenza)
0,166  0,040  Adenylate cyclase stimulant
0,157  0,032  SULT1A1 substrate
0,158  0,034  Coagulant
0,162  0,039  Cholesterol synthesis inhibitor
0,162  0,039  Cyclooxygenase 3 inhibitor
0,181  0,059  Eye irritation, high
0,142  0,021  Antibiotic
0,184  0,063  Succinate dehydrogenase inhibitor
0,155  0,034  Vanilloid 1 agonist
0,133  0,013  Estrogen agonist
0,173  0,053  Heat shock protein 90 antagonist
0,144  0,026  Estrogen antagonist
0,144  0,026  Antifungal (Pneumocystis)
0,146  0,030  Sulfotransferase substrate
0,283  0,167  Antiarthritic
0,167  0,051  Antiprotozoal (Coccidial)
0,129  0,017  HIV-1 integrase (3'-Processing) inhibitor
0,118  0,007  Topoisomerase II beta inhibitor
0,192  0,082  Amyloid beta aggregation inhibitor
0,217  0,108  Flavin-containing monooxygenase substrate
0,188  0,079  Sedative
0,139  0,031  Chronic obstructive bronchitis treatment
0,242  0,136  FMO1 substrate
0,198  0,095  Cyclic AMP phosphodiesterase inhibitor
0,148  0,046  Antitussive
0,106  0,005  Postcoital contraceptive
0,107  0,006  SULT2A1 substrate
0,122  0,022  Interleukin 5 antagonist
0,199  0,100  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,135  0,037  UGT2B1 substrate
0,217  0,120  Radiosensitizer
0,115  0,018  HIV-1 integrase (Strand Transfer) inhibitor
0,183  0,086  VEGF expression inhibitor
0,140  0,044  Carcinogenic, group 2B
0,101  0,005  Lipocortins synthesis agonist
0,163  0,067  Cholinergic
0,132  0,036  Multidrug resistance-associated protein 1 inhibitor
0,123  0,029  Estrogen receptor beta antagonist
0,115  0,021  Glycine receptor antagonist
0,168  0,074  Sigma receptor agonist
0,180  0,087  Anesthetic general
0,135  0,044  Endometrios treatment
0,158  0,067  Antiviral (Influenza A)
0,200  0,110  Vascular (periferal) disease treatment
0,147  0,057  Acetylcholinesterase inhibitor
0,097  0,009  Estrogen receptor alpha agonist
0,161  0,074  Interleukin 6 antagonist
0,099  0,016  Antitreponemal
0,088  0,005  Glucocorticoid antagonist
0,109  0,027  Antiprotozoal activity enhancer
0,092  0,010  Progesterone antagonist
0,142  0,060  Skin whitener
0,141  0,059  Carcinogenic, group 3
0,114  0,035  Paget's disease treatment
0,101  0,025  Dopamine D1 antagonist
0,167  0,091  Antiviral (Hepatitis)
0,121  0,045  Antiprotozoal (Toxoplasma)
0,221  0,146  CYP3A4 inhibitor
0,141  0,068  Neurotrophic factor
0,171  0,098  CYP2B6 inhibitor
0,230  0,158  GST A substrate
0,229  0,160  Antiprotozoal (Plasmodium)
0,158  0,090  Tumour necrosis factor antagonist
0,097  0,029  Estrogen receptor alpha antagonist
0,112  0,044  Prolactin inhibitor
0,132  0,066  Toll-Like receptor 2 antagonist
0,140  0,075  Skeletal muscle relaxant
0,132  0,067  Antihemorrhagic
0,074  0,010  Pregnane X receptor antagonist
0,139  0,076  Hair growth stimulant
0,190  0,130  5 Hydroxytryptamine release stimulant
0,202  0,143  Antihypoxic
0,097  0,040  Inducible nitric-oxide synthase inhibitor
0,078  0,020  Protein 50S ribosomal subunit inhibitor
0,072  0,015  Ryanodine receptor antagonist
0,072  0,015  Glucose-6-phosphate translocase inhibitor
0,157  0,101  Phobic disorders treatment
0,070  0,015  Estradiol 17 beta-dehydrogenase inhibitor
0,136  0,082  SULT1A3 substrate
0,089  0,035  Narcotic antagonist
0,127  0,077  Cocaine dependence treatment
0,095  0,047  ATPase (Vacuolar H+) inhibitor
0,052  0,004  Glucocorticoid agonist
0,073  0,026  Heat shock protein 90 beta antagonist
0,120  0,074  Antiseptic
0,112  0,067  Monophenol monooxygenase inhibitor
0,073  0,028  Antimycoplasmal
0,141  0,096  Heat shock protein 90 alpha antagonist
0,144  0,101  Antipruritic
0,091  0,049  Antispirochetal
0,073  0,031  Andropause treatment
0,169  0,128  Antiviral (HIV)
0,106  0,065  DOPA decarboxylase inhibitor
0,133  0,094  Antidiarrheal
0,139  0,100  Muscle relaxant
0,090  0,052  Granulocyte macrophage colony stimulating factor agonist
0,107  0,068  Electron transport complex I inhibitor
0,084  0,046  Na+ K+ transporting ATPase inhibitor
0,114  0,077  Antiviral (Hepatitis B)
0,118  0,081  Gastritis treatment
0,051  0,015  Hypogonadism treatment
0,160  0,125  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,110  0,075  Proteasome inhibitor
0,087  0,053  Vanilloid agonist
0,052  0,019  Estrogen receptor beta agonist
0,160  0,127  Hypolipemic
0,076  0,044  Glycine receptor agonist
0,077  0,046  CDC25A inhibitor
0,254  0,223  5 Hydroxytryptamine release inhibitor
0,066  0,037  Transcription factor RelA inhibitor
0,068  0,039  Hypercalcemia treatment
0,228  0,201  Alpha-glucosidase inhibitor
0,083  0,056  T cell inhibitor
0,129  0,103  Pregnane X receptor agonist
0,030  0,006  Corticosteroid-like
0,133  0,113  Muscular dystrophy treatment
0,030  0,009  Dopamine D1 agonist
0,048  0,028  Dopamine D2 agonist
0,038  0,018  Tubulin agonist
0,075  0,056  Keratolytic
0,037  0,018  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,132  0,113  CF transmembrane conductance regulator agonist
0,080  0,061  Ca(v)3.1 blocker
0,106  0,088  Retinopathy treatment
0,045  0,028  Dopamine D5 antagonist
0,127  0,110  Prostatic (benign) hyperplasia treatment
0,023  0,007  Antibiotic Anthracycline-like
0,133  0,118  Carcinogenic, group 1
0,039  0,025  Vesicle monoamine transporter inhibitor
0,040  0,027  Dopamine D5 agonist
0,063  0,050  Dopamine agonist
0,022  0,010  Progesterone receptor B antagonist
0,108  0,096  Antihyperlipoproteinemic
0,212  0,200  15-Lipoxygenase inhibitor
0,032  0,020  RNA-directed RNA polymerase stimulant
0,045  0,035  Potassium channel Kv1.3 blocker
0,028  0,018  Hedgehog signaling activator
0,071  0,061  SULT1A2 substrate
0,147  0,137  Insulin sensitizer
0,090  0,080  Skin irritative effect
0,065  0,056  Histidine decarboxylase inhibitor
0,100  0,092  M18 aspartyl aminopeptidase inhibitor
0,128  0,121  Prostate disorders treatment
0,050  0,043  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,016  0,009  Antibiotic Tetracycline-like
0,104  0,098  Antiacne
0,109  0,104  Antihelmintic (Trematoda)
0,111  0,105  Antiparkinsonian, tremor relieving
0,126  0,121  Uterine stimulant
0,072  0,068  Xanthine oxidase substrate
0,081  0,077  Actinic keratosis treatment
0,044  0,040  Mineralocorticoid receptor antagonist
0,063  0,060  HIV-1 integrase inhibitor
0,063  0,061  Prokinetic
0,033  0,031  Antibiotic Aminoglycoside-like
0,083  0,081  Glutamate release inhibitor
0,105  0,104  NADPH oxidase inhibitor

